Erratum: Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis (Breast Cancer Research and Treatment (2011) 129 (37-47) DOI: 10.1007/s10549-010-1177-4);Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis

Breast Cancer Research and Treatment

Volumn 129, Issue 1, 2011, Pages 37-47

  McAllister, Sean D ^a   Murase, Ryuichi ^a   Christian, Rigel T ^a   Lau, Darryl ^a   Zielinski, Anne J ^a   Allison, Juanita ^a   Almanza, Carolina ^a   Pakdel, Arash ^a   Lee, Jasmine ^a   Limbad, Chandani ^a   Liu, Yong ^a   Debs, Robert J ^a   Moore, Dan H ^a   Desprez, Pierre Yves ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Cannabinoid; ERK; Helix loop helix; Id 1; Id 2; Lung metastasis; ROS

Indexed keywords

CANNABIDIOL; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG DOSE COMPARISON; FEMALE; FLOW CYTOMETRY; GENE; GROWTH INHIBITION; HUMAN; HUMAN CELL; ID 1 GENE; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR REGRESSION; UPREGULATION;

EID: 79960835512     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2007-7     Document Type: Erratum

References (48)

1. S Braun N Harbeck 2001 Molecular markers of metastasis in breast cancer: current understanding and prospects for novel diagnosis and prevention Expert Rev Mol Med 3 1 14 14585146 10.1017/S1462399401003520 1:STN:280: DC%2BD3srgvFantA%3D%3D
2. J Perk A Iavarone R Benezra 2005 Id family of helix-loop-helix proteins in cancer Nat Rev Cancer 5 8 603 614 16034366 10.1038/nrc1673 1:CAS:528:DC%2BD2MXmvVCltrc%3D (Pubitemid 41081386)
3. S Fong Y Itahana T Sumida J Singh JP Coppe Y Liu PC Richards JL Bennington NM Lee RJ Debs, et al. 2003 Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis Proc Natl Acad Sci USA 100 23 13543 13548 14578451 10.1073/pnas.2230238100 1:CAS:528:DC%2BD3sXptFOit7g%3D (Pubitemid 37444778)
4. AJ Minn GP Gupta PM Siegel PD Bos W Shu DD Giri A Viale AB Olshen WL Gerald J Massague 2005 Genes that mediate breast cancer metastasis to lung Nature 436 7050 518 524 16049480 10.1038/nature03799 1:CAS:528: DC%2BD2MXmsFCgs7o%3D (Pubitemid 41112921)
5. JP Coppe AP Smith PY Desprez 2003 Id proteins in epithelial cells Exp Cell Res 285 1 131 145 12681293 10.1016/S0014-4827(03)00014-4 1:CAS:528:DC%2BD3sXislCjtbw%3D (Pubitemid 36390161)
6. GP Gupta J Perk S Acharyya P de Candia V Mittal K Todorova-Manova WL Gerald E Brogi R Benezra J Massague 2007 ID genes mediate tumor reinitiation during breast cancer lung metastasis Proc Natl Acad Sci USA 104 49 19506 19511 18048329 10.1073/pnas.0709185104 1:CAS:528:DC%2BD1cXisVOgsw%3D%3D
7. A Swarbrick E Roy T Allen JM Bishop 2008 Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response Proc Natl Acad Sci USA 105 14 5402 5407 18378907 10.1073/pnas.0801505105 1:CAS:528:DC%2BD1cXkslSnsL8%3D (Pubitemid 351753875)
8. RG Pertwee 1997 Pharmacology of cannabinoid CB1 and CB2 receptors Pharmacol Ther 74 November 129 180 9336020 10.1016/S0163-7258(97)82001-3 1:CAS:528:DyaK2sXkvFChsL0%3D (Pubitemid 27337346)
9. JM McPartland EB Russo 2001 Cannabis and cannabis extract: greater than the sum of the parts? J Cannabis Ther 1 103 132 10.1300/J175v01n03-08 1:CAS:528:DC%2BD3MXoslSrt7g%3D
10. SD McAllister M Glass 2002 CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids Prostaglandins Leukot Essent Fatty Acids 66 2-3 161 171 12052033 10.1054/plef.2001.0344 1:CAS:528:DC%2BD38Xlt1Kksr4%3D (Pubitemid 34743592)
11. VM Showalter DR Compton BR Martin ME Abood 1996 Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands J Pharmacol Exp Ther 278 989 999 8819477 1:CAS:528:DyaK28XmtVSjs74%3D (Pubitemid 27166944)
12. SO Alozie BR Martin LS Harris WL Dewey 1980 3H-delta 9- Tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: penetration and regional distribution in rat brain Pharmacol Biochem Behav 12 2 217 218 6246544 10.1016/0091-3057(80)90359-7 1:CAS:528:DyaL3cXks1Sru74%3D
13. L Walter A Franklin A Witting C Wade Y Xie G Kunos K Mackie N Stella 2003 Nonpsychotropic cannabinoid receptors regulate microglial cell migration J Neurosci 23 4 1398 1405 12598628 1:CAS:528:DC%2BD3sXit1antb0%3D (Pubitemid 36258918)
14. KT Brady RL Balster 1980 The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys Psychopharmacology 72 1 21 26 6258188 10.1007/BF00433803 1:CAS:528:DyaL3MXlvVeitA%3D%3D (Pubitemid 11197762)
15. AJ Hiltunen TU Jarbe 1986 Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol Eur J Pharmacol 125 2 301 304 3017729 10.1016/0014-2999(86)90042-7 1:CAS:528:DyaL28XksFCmtLY%3D (Pubitemid 16075445)
16. AJ Hiltunen TU Jarbe K Wangdahl 1988 Cannabinol and cannabidiol in combination: temperature, open-field activity, and vocalization Pharmacol Biochem Behav 30 3 675 678 3211977 10.1016/0091-3057(88)90082-2 1:CAS:528:DyaL1cXlt1ansb8%3D (Pubitemid 19271151)
17. LE Hollister H Gillespie 1975 Interactions in man of delta-9- tetrahydrocannabinol. II. cannabinol and cannabidiol Clin Pharmacol Ther 18 1 80 83 1097148 1:CAS:528:DyaE2MXlsVajtb4%3D
18. Abood ME, Raman C, Kim K, Moore DH (2004) Evaluation of cannabidiol in the ALS mouse model. In: ALS and other motor neuron diseases, 2-4 December 2004. Talyor and Francis, Philadelphia, USA, pp 92-93 (poster 61)
19. TJ Nurmikko MG Serpell B Hoggart PJ Toomey BJ Morlion D Haines 2007 Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial Pain 133 1-3 210 220 17997224 10.1016/j.pain.2007.08.028 1:CAS:528:DC%2BD2sXhtlGjsbfE (Pubitemid 350141682)
20. DJ Rog TJ Nurmikko CA Young 2007 Oromucosal delta9-tetrahydrocannabinol/ cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial Clin Ther 29 9 2068 2079 18035205 10.1016/j.clinthera.2007.09.013 1:CAS:528:DC%2BD2sXhtlakt7jL (Pubitemid 350218115)
21. SD McAllister RT Christian MP Horowitz A Garcia PY Desprez 2007 Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells Mol Cancer Ther 6 11 2921 2927 18025276 10.1158/1535-7163.MCT-07- 0371 1:CAS:528:DC%2BD2sXhtlWkt7bN (Pubitemid 350206770)
22. A Ligresti AS Moriello K Starowicz I Matias S Pisanti L De Petrocellis C Laezza G Portella M Bifulco V Di Marzo 2006 Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma J Pharmacol Exp Ther 318 3 1375 1387 16728591 10.1124/jpet.106.105247 1:CAS:528:DC%2BD28XovFygtLY%3D (Pubitemid 44268348)
23. BL Kaplan AE Springs NE Kaminski 2008 The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT) Biochem Pharmacol 76 6 726 737 18656454 10.1016/j.bcp.2008.06.022 1:CAS:528:DC%2BD1cXhtVyku7bJ
24. AM Malfait R Gallily PF Sumariwalla AS Malik E Andreakos R Mechoulam M Feldmann 2000 The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis Proc Natl Acad Sci USA 97 17 9561 9566 10920191 10.1073/pnas.160105897 1:CAS:528: DC%2BD3cXmtVensbs%3D (Pubitemid 30650815)
25. SD McAllister C Chan RJ Taft T Luu ME Abood DH Moore K Aldape G Yount 2005 Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells J NeuroOncol 74 1 31 40 16078104 10.1007/s11060-004-5950-2 1:CAS:528:DC%2BD2MXhtlSgsL3M (Pubitemid 41194527)
26. CQ Lin J Singh K Murata Y Itahana S Parrinello SH Liang CE Gillett J Campisi PY Desprez 2000 A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells Cancer Res 60 5 1332 1340 10728695 1:CAS:528:DC%2BD3cXhvFWrt7o%3D (Pubitemid 30152003)
27. M Guzman 2003 Cannabinoids: potential anticancer agents Nat Rev Cancer 3 10 745 755 14570037 10.1038/nrc1188 1:CAS:528:DC%2BD3sXotFCiu7c%3D (Pubitemid 37328813)
28. RJ McKallip W Jia J Schlomer JW Warren PS Nagarkatti M Nagarkatti 2006 Cannabidiol-induced apoptosis in human leukemia cells: a novel role of cannabidiol in the regulation of p22phox and Nox4 expression Mol Pharmacol 70 3 897 908 16754784 10.1124/mol.106.023937 1:CAS:528:DC%2BD28Xps1SmsLg%3D (Pubitemid 44268447)
29. R Ramer B Hinz 2008 Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1 J Natl Cancer Inst 100 1 59 69 18159069 10.1093/jnci/djm268 1:CAS:528: DC%2BD1cXit1Cku7g%3D (Pubitemid 351767340)
30. Y Itahana J Singh T Sumida JP Coppe S Parrinello JL Bennington PY Desprez 2003 Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells Cancer Res 63 21 7098 7105 14612502 1:CAS:528:DC%2BD3sXovVGlsLc%3D (Pubitemid 37413446)
31. M Stighall C Manetopoulos H Axelson G Landberg 2005 High ID2 protein expression correlates with a favourable prognosis in patients with primary breast cancer and reduces cellular invasiveness of breast cancer cells Int J Cancer 115 3 403 411 15688367 10.1002/ijc.20875 1:CAS:528:DC%2BD2MXkt1Clur0%3D (Pubitemid 40663744)
32. P Massi A Vaccani S Bianchessi B Costa P Macchi D Parolaro 2006 The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells Cell Mol Life Sci 63 17 2057 2066 16909207 10.1007/s00018-006-6156-x 1:CAS:528:DC%2BD28XhtVCjt7%2FI (Pubitemid 44359745)
33. MH Andersen RB Sorensen D Schrama IM Svane JC Becker P Thor Straten 2008 Cancer treatment: the combination of vaccination with other therapies Cancer Immunol Immunother 57 11 1735 1743 18286284 10.1007/s00262-008-0480-y 1:CAS:528:DC%2BD1cXhtVejsbfM
34. S Fong RJ Debs PY Desprez 2004 Id genes and proteins as promising targets in cancer therapy Trends Mol Med 10 8 387 392 15310459 10.1016/j.molmed.2004. 06.008 1:CAS:528:DC%2BD2cXmsVCrtrY%3D (Pubitemid 39061140)
35. MT Ling X Wang X Zhang YC Wong 2006 The multiple roles of Id-1 in cancer progression Differentiation 74 9-10 481 487 17177845 10.1111/j.1432-0436.2006. 00083.x 1:CAS:528:DC%2BD2sXmslI%3D (Pubitemid 44922493)
36. P Derkinderen H Enslen JA Girault 1999 The ERK/MAP-kinases cascade in the nervous system Neuroreport 10 5 R24 R34 10321455 1:CAS:528:DyaK1MXkt1Chtr8%3D
37. KM Pumiglia SJ Decker 1997 Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway Proc Natl Acad Sci USA 94 2 448 452 9012803 10.1073/pnas.94.2.448 1:CAS:528:DyaK2sXnslagsw%3D%3D (Pubitemid 27053653)
38. S Mohr TS McCormick EG Lapetina 1998 Macrophages resistant to endogenously generated nitric oxide-mediated apoptosis are hypersensitive to exogenously added nitric oxide donors: dichotomous apoptotic response independent of caspase 3 and reversal by the mitogen-activated protein kinase kinase (MEK) inhibitor PD 098059 Proc Natl Acad Sci USA 95 9 5045 5050 9560225 10.1073/pnas.95.9.5045 1:CAS:528:DyaK1cXivV2js7k%3D (Pubitemid 28208547)
39. RD York H Yao T Dillon CL Ellig SP Eckert EW McCleskey PJ Stork 1998 Rap1 mediates sustained MAP kinase activation induced by nerve growth factor Nature 392 6676 622 626 9560161 10.1038/33451 1:CAS:528:DyaK1cXis1Wjtrs%3D (Pubitemid 28207722)
40. I Galve-Roperh C Sanchez ML Cortes TG del Pulgar M Izquierdo M Guzman 2000 Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation Nat Med 6 3 313 319 10700234 10.1038/73171 1:CAS:528:DC%2BD3cXhslygs7w%3D (Pubitemid 30148624)
41. S Sarfaraz F Afaq VM Adhami A Malik H Mukhtar 2006 Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest J Biol Chem 281 51 39480 39491 17068343 10.1074/jbc.M603495200 1:CAS:528:DC%2BD28XhtlagsLfI (Pubitemid 46041908)
42. G Velasco I Galve-Roperh C Sanchez C Blazquez M Guzman 2004 Hypothesis: cannabinoid therapy for the treatment of gliomas? Neuropharmacology 47 3 315 323 15275820 10.1016/j.neuropharm.2004.04.016 1:CAS:528:DC%2BD2cXmtVCjtLk%3D (Pubitemid 38953222)
43. FM Mo L Offertaler G Kunos 2004 Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1 Eur J Pharmacol 489 1-2 21 27 15063151 10.1016/j.ejphar.2004.02.034 1:CAS:528:DC%2BD2cXisl2rs7w%3D (Pubitemid 38520067)
44. JD Lambeth 2004 NOX enzymes and the biology of reactive oxygen Nat Rev Immunol 4 3 181 189 15039755 10.1038/nri1312 1:CAS:528:DC%2BD2cXitlSnsbY%3D (Pubitemid 38339084)
45. M Mimeault R Hauke SK Batra 2008 Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies Clin Pharmacol Ther 83 5 673 691 17786164 10.1038/sj.clpt.6100296 1:CAS:528:DC%2BD1cXkvVegsrs%3D (Pubitemid 351559599)
46. MD Cameron EE Schmidt N Kerkvliet KV Nadkarni VL Morris AC Groom AF Chambers IC MacDonald 2000 Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency Cancer Res 60 9 2541 2546 10811137 1:CAS:528:DC%2BD3cXjtV2qtb4%3D (Pubitemid 30262450)
47. J Folkman 1990 What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 1 4 6 1688381 10.1093/jnci/82.1.4 1:STN:280:DyaK3c%2FnvF2qug%3D%3D (Pubitemid 20020880)
48. P Dent DT Curiel PB Fisher S Grant 2009 Synergistic combinations of signaling pathway inhibitors: mechanisms for improved cancer therapy Drug Resist Updat 12 3 65 73 19395305 10.1016/j.drup.2009.03.001 1:CAS:528: DC%2BD1MXnt1ehsrw%3D